U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07183735) titled 'A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance' on Aug. 07.
Brief Summary: This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.
Study Start Date: July 02, 2024
Study Type: INTERVENTIONAL
Condition:
Sleep
Sleep Disorder
Intervention:
DIETARY_SUPPLEMENT: BEAM Dream Powder
A powdered sleep supplement. Administered daily, mixed with ...